We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$785M
AUM Growth
+$300M
Cap. Flow
+$256M
Cap. Flow %
32.59%
Top 10 Hldgs %
45.64%
Holding
72
New
25
Increased
20
Reduced
11
Closed
13

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$27M
2
ENR icon
Energizer
ENR
+$19M
3
PLYA
Playa Hotels & Resorts
PLYA
+$13.2M
4
BBBY
Bed Bath & Beyond Inc
BBBY
+$12.7M
5
GCI
Gannett Co., Inc
GCI
+$12.7M

Top Sells

Rank Stock Value
1
KATE
Kate Spade & Company
KATE
+$13.3M
2
DECK icon
Deckers Outdoor
DECK
+$10.8M
3
VSTO
Vista Outdoor Inc.
VSTO
+$9.27M
4
ATRS
Antares Pharma, Inc.
ATRS
+$8.5M
5
SAM icon
Boston Beer
SAM
+$7.81M

Sector Composition

Rank Sector Weight
1 Healthcare 31.65%
2 Consumer Discretionary 21.97%
3 Consumer Staples 11.32%
4 Industrials 3.49%
5 Communication Services 1.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
51
DELISTED
bluebird bio
BLUE
$2.94M 0.37%
2,162
+309
+17% +$373K
KPRX icon
52
Kiora Pharmaceuticals
KPRX
$11.7M
$2.21M 0.28%
+299
New +$2.95M
AVTX icon
53
Avalo Therapeutics
AVTX
$1.02B
$1.94M 0.25%
+1,175
New +$1.92M
TLRD
54
DELISTED
Tailored Brands, Inc.
TLRD
$1.67M 0.21%
150,000
-138,000
-48% -$1.61M
JILL icon
55
J. Jill
JILL
$248M
$1.62M 0.21%
+31,442
New +$1.69M
DYNT
56
DELISTED
Dynatronics Corp
DYNT
$1.4M 0.18%
100,000
– –
ATEC icon
57
Alphatec Holdings
ATEC
$1.31B
$992K 0.13%
536,414
-6,000
-1% -$12.1K
VXRT
58
DELISTED
Vaxart
VXRT
$752K 0.1%
+102,075
New +$610K
ABUS icon
59
Arbutus Biopharma
ABUS
$901M
– –
-1,600,000
Closed -$5.2M
DECK icon
60
Deckers Outdoor
DECK
$14.8B
– –
-1,032,000
Closed -$10.8M
DKS icon
61
Dick's Sporting Goods
DKS
$19.5B
– –
-100,000
Closed -$4.87M
LRMR icon
62
Larimar Therapeutics
LRMR
$384M
– –
-9,333
Closed -$522K
SAM icon
63
Boston Beer
SAM
$1.86B
– –
-54,000
Closed -$7.81M
WSM icon
64
Williams-Sonoma
WSM
$26.9B
– –
-104,000
Closed -$2.79M
TLRD
65
CALL
DELISTED
Tailored Brands, Inc.
TLRD
– –
-160,000
Closed -$2.39M
DFRG
66
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
– –
-240,000
Closed -$4.33M
WFM
67
CALL
DELISTED
Whole Foods Market Inc
WFM
– –
-700,000
Closed -$20.8M
KATE
68
DELISTED
Kate Spade & Company
KATE
– –
-572,000
Closed -$13.3M
PDLI
69
DELISTED
PDL BioPharma, Inc.
PDLI
– –
-500,000
Closed -$1.14M
VSTO
70
DELISTED
Vista Outdoor Inc.
VSTO
– –
-450,000
Closed -$9.27M
ARLZ
71
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
– –
-700,000
Closed -$1.5M
1 2
3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Armistice Capital held 72 positions worth $785M, up 62% from $484M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Armistice Capital deployed $256M of net new capital in Q2 2017, opening 25 new positions and adding to 20 existing holdings. Its largest new stake was Assertio: 40,533 shares worth $26.1M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Antares Pharma, Inc., an estimated $8.5M trimmed.

  • Armistice Capital's largest Q2 2017 buy was Assertio: 40,533 shares worth $26.1M.
  • Armistice Capital added most to Hain Celestial in Q2 2017, an estimated $9.54M increase.
  • Armistice Capital's biggest Q2 2017 reduction was Antares Pharma, Inc., cutting an estimated $8.5M.
  • Armistice Capital fully exited Kate Spade & Company in Q2 2017, selling an estimated $13.3M.
  • Armistice Capital's ten largest holdings make up 46% of its $785M portfolio in Q2 2017.
  • Armistice Capital opened 25 new positions and closed 13 in Q2 2017.
  • Armistice Capital's portfolio value rose 62% quarter-over-quarter to $785M.

Based on Armistice Capital's 13F filing for Q2 2017, filed 14 Aug 2017.